CME Group (NASDAQ: CME) has appointed Vijay Albuquerque as Chief Risk Officer for its Clearing & Post-Trade Services Division, the company announced today (Thursday).

Albuquerque joins CME Group after more than two decades at Citigroup, where he most recently served as Managing Director and Head of Counterparty Risk and Portfolio Risk Analytics for the bank's Markets and Banking businesses.

CME Group Names Vijay Albuquerque as New Chief Risk Officer

Albuquerque brings extensive risk management experience to the role. At Citigroup, he oversaw the firm-wide stress testing platform across derivatives, financing and lending products, while managing counterparty exposure and funds credit underwriting.

Previously, he served as Global Head of Risk for Citi's Futures & OTC Clearing Business, where he managed counterparty risk, regulatory capital and liquidity risk.

"After two decades at Citi, I’m happy to share that I have started a new position as Chief Risk Officer (CRO) at CME Group," Albuquerque commented. "CME is at the forefront of financial product innovation and industry-leading risk management and I look forward to working with a talented team at CME."

Based in New York, he will report to Suzanne Sprague, CME Group's Chief Operating Officer and Global Head of Clearing.

"Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our clients," Sprague said in a statement.

His career at Citigroup spanned multiple positions over 20 years, including roles as Senior Vice President and Credit Officer for hedge funds. Prior to joining Citigroup, Albuquerque worked at Oracle for five years as a Senior Project Leader.

CME Group operates the world's leading derivatives marketplace, offering trading in futures, options, cash and over-the-counter markets. The company's exchanges provide trading platforms for interest rates, equity indexes, foreign exchange, energy, agricultural products and metals.

Revenue Hits Record $1.6 Billion

The appointment comes as CME Group reports strong financial performance. The company recently announced record first-quarter results, with revenue reaching $1.6 billion amid increased client hedging activity across all asset classes. Operating income rose to $1.1 billion, while net income reached $956 million, or $1.0 billion on an adjusted basis.

Foreign exchange trading has been particularly robust, with daily FX volumes averaging 1.15 million contracts in the first quarter, representing a 16.8% increase compared to the same period last year.

The company's cryptocurrency derivatives segment has shown even more visible growth. Trading volumes surged nearly 60% in March alone, with the exchange reporting $11.3 billion in notional value for its crypto derivatives products. This growth has been primarily driven by micro Bitcoin and Ethereum futures contracts